IMVT
Price
$35.15
Change
+$4.62 (+15.13%)
Updated
Nov 9 closing price
Capitalization
6.31B
98 days until earnings call
Intraday BUY SELL Signals
MTVA
Price
$1.61
Change
+$0.18 (+12.59%)
Updated
Nov 9 closing price
Capitalization
9.42M
142 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IMVT vs MTVA

IMVT vs MTVA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
IMVT vs. MTVA commentary
Nov 10, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMVT is a Hold and MTVA is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for IMVT with price predictions
Nov 09, 2026

IMVT's Indicator enters downward trend

The Aroon Indicator for IMVT entered a downward trend on October 27, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 225 similar instances where the Aroon Indicator formed such a pattern. In 193 of the 225 cases the stock moved lower. This puts the odds of a downward move at 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMVT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

IMVT broke above its upper Bollinger Band on November 06, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on IMVT as a result. In 77 of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.

The Moving Average Convergence Divergence (MACD) for IMVT just turned positive on October 22, 2026. Looking at past instances where IMVT's MACD turned positive, the stock continued to rise in 30 of 44 cases over the following month. The odds of a continued upward trend are 68%.

IMVT moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +23.81% 3-day Advance, the price is estimated to grow further. Considering data from situations where IMVT advanced for three days, in 203 of 265 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 31 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.575) is normal, around the industry mean (3.498). P/E Ratio (-10.865) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron Profit vs. Risk Rating rating for this company is 50 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock slightly better than average.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. IMVT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

A.I.Advisor
a Summary for MTVA with price predictions
Nov 09, 2026

MTVA in downward trend: 10-day moving average crossed below 50-day moving average on October 07, 2026

The 10-day moving average for MTVA crossed bearishly below the 50-day moving average on October 07, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 11 of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MTVA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

MTVA broke above its upper Bollinger Band on November 09, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for MTVA entered a downward trend on November 06, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where MTVA's RSI Indicator exited the oversold zone, 33 of 42 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 47 of 60 cases where MTVA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

The Momentum Indicator moved above the 0 level on November 06, 2026. You may want to consider a long position or call options on MTVA as a result. In 70 of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 77%.

The Moving Average Convergence Divergence (MACD) for MTVA just turned positive on November 04, 2026. Looking at past instances where MTVA's MACD turned positive, the stock continued to rise in 32 of 38 cases over the following month. The odds of a continued upward trend are 84%.

MTVA moved above its 50-day moving average on November 09, 2026 date and that indicates a change from a downward trend to an upward trend.

Following a +47.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where MTVA advanced for three days, in 181 of 222 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of 58 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.381) is normal, around the industry mean (3.498). P/E Ratio (-0.584) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).

The Tickeron Price Growth Rating for this company is 60 (best 1 - 100 worst), indicating steady price growth. MTVA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MTVA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

FUNDAMENTALS RATINGS
IMVT vs MTVA: Fundamental Ratings
IMVT
MTVA
OUTLOOK RATING
1..100
2728
VALUATION
overvalued / fair valued / undervalued
1..100
31
Undervalued
58
Fair valued
PROFIT vs RISK RATING
1..100
50100
SMR RATING
1..100
9899
PRICE GROWTH RATING
1..100
5760
P/E GROWTH RATING
1..100
2027
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMVT's Valuation (31) in the null industry is in the same range as MTVA (58). This means that IMVT’s stock grew similarly to MTVA’s over the last 12 months.

IMVT's Profit vs Risk Rating (50) in the null industry is somewhat better than the same rating for MTVA (100). This means that IMVT’s stock grew somewhat faster than MTVA’s over the last 12 months.

IMVT's SMR Rating (98) in the null industry is in the same range as MTVA (99). This means that IMVT’s stock grew similarly to MTVA’s over the last 12 months.

IMVT's Price Growth Rating (57) in the null industry is in the same range as MTVA (60). This means that IMVT’s stock grew similarly to MTVA’s over the last 12 months.

IMVT's P/E Growth Rating (20) in the null industry is in the same range as MTVA (27). This means that IMVT’s stock grew similarly to MTVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMVTMTVA
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
79%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
80%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
82%
Declines
ODDS (%)
Bearish Trend 8 days ago
81%
Bearish Trend 13 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Nov 10, 2026
Stock price -- (IMVT: $30.53 vs. MTVA: $1.43)
Brand notoriety: IMVT and MTVA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMVT: 214% vs. MTVA: 780%
Market capitalization -- IMVT: $6.31B vs. MTVA: $9.42M
IMVT [@Biotechnology] is valued at $6.31B. MTVA’s [@Biotechnology] market capitalization is $9.42M. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMVT’s FA Score shows that 2 FA rating(s) are green while MTVA’s FA Score has 1 green FA rating(s).

  • IMVT’s FA Score: 2 green, 3 red.
  • MTVA’s FA Score: 1 green, 4 red.
According to our system of comparison, IMVT is a better buy in the long-term than MTVA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMVT’s TA Score shows that 4 TA indicator(s) are bullish while MTVA’s TA Score has 6 bullish TA indicator(s).

  • IMVT’s TA Score: 4 bullish, 4 bearish.
  • MTVA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, MTVA is a better buy in the short-term than IMVT.

Price Growth

IMVT (@Biotechnology) experienced а +4.66% price change this week, while MTVA (@Biotechnology) price change was +27.68% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.97%. For the same industry, the average monthly price growth was -8.33%, and the average quarterly price growth was +85.08%.

Reported Earning Dates

IMVT is expected to report earnings on Feb 16, 2027.

MTVA is expected to report earnings on Apr 01, 2027.

Industries' Descriptions

@Biotechnology (+2.97% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

IMVT and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMVT has been loosely correlated with ROIV. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if IMVT jumps, then ROIV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMVT
1D Price
Change %
IMVT100%
+15.13%
ROIV - IMVT
64%
Loosely correlated
+4.60%
LXEO - IMVT
50%
Loosely correlated
+8.65%
KURA - IMVT
48%
Loosely correlated
+4.13%
XNCR - IMVT
48%
Loosely correlated
+7.94%
TSHA - IMVT
47%
Loosely correlated
+0.92%
More

MTVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTVA has been loosely correlated with PMVP. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MTVA jumps, then PMVP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTVA
1D Price
Change %
MTVA100%
+12.59%
PMVP - MTVA
35%
Loosely correlated
-0.79%
SPRB - MTVA
34%
Loosely correlated
+5.99%
KPRX - MTVA
30%
Poorly correlated
+4.86%
IMVT - MTVA
30%
Poorly correlated
+15.13%
IMTX - MTVA
28%
Poorly correlated
+1.10%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FESM45.771.44
+3.25%
Fidelity Enhanced Small Cap Core ETF (FESM)
WEEL19.800.29
+1.50%
Peerless Option Income Wheel ETF (WEEL)
GPRF47.970.13
+0.27%
Goldman Sachs Access U.S. Preferred Stock and Hybrid Securities ETF (GPRF)
IBHF22.49N/A
N/A
iShares iBonds 2026 Term High Yield and Income ETF (IBHF)
MYMF24.85-0.02
-0.08%
State Street My2026 Municipal Bond ETF (MYMF)